IO Biotech
IOBT
IOBT
19 hedge funds and large institutions have $30.6M invested in IO Biotech in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
35% less capital invested
Capital invested by funds: $47.4M → $30.6M (-$16.7M)
Holders
19
Holding in Top 10
1
Calls
$1.16M
Puts
–
Top Buyers
| 1 | +$225K | |
| 2 | +$33.1K | |
| 3 | +$15.9K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.5K |
| 5 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
+$4.87K |
Top Sellers
| 1 | -$771K | |
| 2 | -$270K | |
| 3 | -$263K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$225K |
| 5 |
AC
Armistice Capital
New York
|
-$209K |